Basiliximab Intravenous and Lithium Carbonate Tablets
Determining the interaction of Basiliximab Intravenous and Lithium Carbonate Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: basiliximab
Brand name: Simulect
Synonyms: Basiliximab
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Basiliximab Intravenous-Lithium Citrate Syrup
- Basiliximab Intravenous-Lithium Controlled-Release and Extended-Release Tablets
- Basiliximab Intravenous-Lithium ER
- Basiliximab Intravenous-Lithium Oral Solution
- Basiliximab Intravenous-Lithium Salts
- Basiliximab Intravenous-Lithium Syrup and Oral Solution
- Lithium Carbonate Tablets-Bavencio
- Lithium Carbonate Tablets-Baxdela
- Lithium Carbonate Tablets-Baxdela (Delafloxacin Injection)
- Lithium Carbonate Tablets-Baxdela (Delafloxacin Tablets)
- Lithium Carbonate Tablets-Baxdela Intravenous
- Lithium Carbonate Tablets-Baycadron